Safe medical treatment in Palliative care - Pharmaceutical analysis of palliativ care medication process
Not Applicable
Recruiting
- Conditions
- Z51.5Palliative care
- Registration Number
- DRKS00013591
- Lead Sponsor
- Klinik und Poliklinik für PalliativmedizinKlinikum der Universtität München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
incurable disease (malignant or non-malignant)
- >18 years
- inpatient (St. Josefs-Hospital Wiesbaden oder Helios HSK Wiesbaden)
- communication (german/english)
- Statement of agreement
Exclusion Criteria
Person who are unable to give their consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method drug-related problems (inpatient, outpatient)<br>Classification drug related problems (PCNE V8.1)
- Secondary Outcome Measures
Name Time Method - Deviations between inpatient medication and medication 7 days after discharge from the hospital<br>- Interactions: inpatient (day 2, last day), 7 days after discharge from the hospital <br>- pharmacist visits patient at home 7 days after discharge from the hospital<br>- unplaned admission in the hospital<br>- Change in clinical symptoms
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie medication safety in DRKS00013591 palliative care trial?
How does DRKS00013591 compare to standard-of-care in managing adverse events for palliative care patients?
What biomarkers are associated with optimal medication response in Z51.5 palliative care interventions?
Are there combination therapies being explored alongside DRKS00013591 for enhanced palliative care outcomes?
What pharmaceutical strategies improve medication processes in University Hospital Munich's interventional palliative care study?